COVID-19 Depression Scale

Abstract

The COVID-19 Depression Scale (COVID-19DS) is an empirically validated psychometric instrument designed to quantify and screen for depressive symptomatology specifically precipitated by the COVID-19 pandemic. Developed by psychometrics researchers Mahboubeh Dadfar, the late suicidologist David Lester, and Yahya Turan, the instrument was conceptualized to address the critical need for a situationally anchored assessment tool capable of differentiating general depressive phenotypes from pandemic-reactive depressive states. Originally drafted in Persian (Farsi) and validated in Turkish and English cohorts, the scale comprises 16 self-report items administered via a five-point Likert-type response continuum ranging from 0 (Not at all) to 4 (Nearly every day over the last 2 weeks), yielding a total cumulative score between 0 and 64.

Structural validation through exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) established a stable, correlated two-factor latent framework accounting for 57.22% of total cumulative variance: Factor 1, designated as Affective, Cognitive, and Somatic/Vegetative manifestations, and Factor 2, termed COVID-19 Depression (capturing acute contagion-specific anxieties, isolation distress, bereavement, and disruptions to religious/communal rituals). The instrument exhibits exceptional internal consistency, demonstrated by a global Cronbach’s alpha of .92. Criterion-related, convergent, and construct validities are substantiated by statistically significant inverse correlations with perceived health-related physical and psychological components, as well as documented gender disparities congruent with global epidemiological depression literature. The COVID-19DS functions as an efficient primary screener in clinical, community, and university settings to identify individuals experiencing severe reactive psychological distress who warrant targeted psychiatric evaluation and evidence-based psycho-educational or psychotherapeutic interventions.

Keywords

COVID-19 Depression Scale, COVID-19DS, Pandemic-Related Depression, Affective Symptoms, Somatic Distress, Major Depressive Disorder, Psychometrics, Factor Analysis, Mental Health Screening, Perceived Health

Authors

The COVID-19 Depression Scale was developed and standardized through an international academic collaboration:

• Mahboubeh Dadfar, Ph.D.: Associate Professor of Clinical Psychology, School of Behavioral Sciences and Mental Health (Iran University of Medical Sciences / Tehran Institute of Psychiatry), Tehran, Iran. ORCID: 0000-0003-0620-2570. Corresponding Email: [email protected] / [email protected].
• David Lester, Ph.D.: Distinguished Emeritus Professor of Psychology, Psychology Program, Stockton University, Galloway, New Jersey, United States. Renowned worldwide for foundational contributions to suicidology, affect assessment, and psychological measurement.
• Yahya Turan, Ph.D.: Associate Professor, Faculty of Islamic Sciences, Department of Philosophy and Religious Sciences, Psychology of Religion Division, Bandırma Onyedi Eylül University, Bandırma, Balıkesir, Turkey.

Purpose

The emergence of the coronavirus disease 2019 pandemic initiated an unprecedented disruption of global public health, civil liberties, socioeconomic stability, and routine daily life. In response, epidemiological investigations documented dramatic worldwide escalations in affective disorders, generalized anxiety, and acute stress. However, conventional depressive assessment tools—such as the Patient Health Questionnaire-9 (PHQ-9) or the Beck Depression Inventory-II (BDI-II)—were structured around context-free manifestations of endogenous or clinical Major Depressive Disorder. Consequently, these instruments are unequipped to delineate whether an individual’s affective collapse, anhedonia, or somatic fatigue represents a chronic endogenous depressive episode or an acute, context-specific neurobiological and psychological reaction to the contagion threat, containment policies, social isolation, and mortality salience induced by the pandemic.

To overcome this diagnostic ambiguity, Dadfar, Lester, and Turan (2023) developed the COVID-19 Depression Scale (COVID-19DS). The primary psychometric purposes of the instrument encompass:

• Pandemic-Attributed Affective Screening: Quantifying depressive symptomatology directly linked to COVID-19 stressors via an anchored response stem (“The COVID-19 makes me:”), ensuring that respondents explicitly contextualize their responses around pandemic circumstances.
• Differential Phenotypic Assessment: Permitting clinicians and clinical researchers to compare post-COVID affective states with classic major depressive episodes, tracking how external pandemic crises modulate internal vegetative, emotional, and cognitive markers.
• Triage and Preventive Intervention: Serving as a rapid, reliable screener in outpatient facilities, university health clinics, and occupational settings to detect individuals with critical elevations in symptom burden who are vulnerable to clinical deterioration, functional impairment, or self-harm.
• Public Health Monitoring: Providing epidemiologists, health psychologists, and public health authorities with a standardized psychometric marker to monitor population-level resilience and the residual psychological impact of sanitary restrictions, social distancing mandates, and community bereavement.

Psychological Construct

The construct assessed by the COVID-19DS is multidimensional pandemic-precipitated depression. Rooted in clinical affective science, the tool operationalizes depression not merely as an isolated psychological state, but as a dual-faceted phenomenon comprising core biological/cognitive disturbances alongside situation-specific pandemic stressors. Confirmatory empirical modeling isolates two foundational dimensions:

1. Affective, Cognitive, and Somatic/Vegetative Dimension

This primary latent construct reflects classical neurovegetative and cognitive-affective manifestations of depression modulated by prolonged crisis exposure. Grounded in the diagnostic paradigms of the DSM-5 and ICD-11, this dimension encapsulates systemic biological and affective depletion, including:

• Pervasive Dysphoric Mood and Anhedonia: Loss of subjective positive valence, persistent despondency, and an inability to experience pleasure in previously rewarding hobbies, recreation, or vocational engagements (Items 1 and 2).
• Vegetative Energetic Exhaustion: Substantial depletion of baseline physical energy, muscular lethargy, and heightened subjective fatigue that persists independently of physical exertion (Items 4 and 5).
• Cognitive Impairment and Executive Dysfunction: Difficulties in decision-making capacity, concentration lapses, and cognitive paralysis in navigating mundane daily dilemmas under constant public health uncertainty (Item 8).
• Existential Nihilism and Negative Self-Schema: Feelings of worthlessness, unwarranted pathological guilt, perceived burden on others, pervasive internal emptiness, and passive or active suicidal ideation / thoughts of mortality (Items 6, 7, 9, and 10).

2. COVID-19 Depression (Pandemic-Specific Distress)

The second latent construct evaluates reactive affective and behavioral sequelae directly induced by external COVID-19 disruptions. It reflects emotional dysregulation generated by the unique behavioral mandates and existential threats of the pandemic, encompassing:

• Somatic Reactivity: Destabilization of homeostatic appetite regulation (marked shifts toward hyperphagia or severe anorexia) arising as a direct stress-response to contagion threats (Item 3).
• Contagion Anxiety and Vicarious Bereavement: Acute feelings of sadness, panic, or grief when contemplating personal vulnerability or the potential infection, hospitalization, or death of loved ones, friends, and family members (Items 11 and 12).
• Isolation and Quarantine Despondency: The demoralizing impact of forced physical confinement, room confinement, loss of physical touch, and the psychological trauma of quarantine regimens (Items 13 and 15).
• Media-Induced Affective Flooding: Exacerbation of depressive despondency triggered by continuous consumption of catastrophic pandemic journalism, death tallies, and crisis broadcasting (Item 14).
• Socio-Spiritual Disconnection: Melancholia resulting from the systemic cessation of communal religious worship, fellowship, congregational ceremonies, and traditional spiritual support systems that historically serve as vital cultural coping resources (Item 16).

Theoretical Framework

The architectural foundation of the COVID-19DS rests at the intersection of several established theoretical paradigms within affective psychology, stress science, and clinical psychometrics:

The Diathesis-Stress Model

According to the classical diathesis-stress framework (e.g., Monroe & Simons, 1991), psychopathology emerges when an underlying vulnerability (genetic, cognitive, or biological) intersects with environmental stressors of sufficient magnitude. The COVID-19 pandemic served as a universal, chronic macro-stressor. For millions of individuals without prior psychiatric history, the severity, chronicity, and unpredictability of the pathogen threat, combined with forced lifestyle alterations, exceeded physiological and psychological coping thresholds, converting latent vulnerabilities into explicit depressive phenotypes measured by the COVID-19DS.

Cognitive Theory of Depression

Aaron T. Beck’s cognitive triad posits that depression is driven by systematized negative views of the self, the world, and the future (Beck, 1979). In the context of the COVID-19 pandemic, this cognitive triad was continuously reinforced by objective reality:

• The Self: Perceived as biologically vulnerable, helpless against an invisible virus, or morally deficient (Items 6 and 7).
• The World: Interpreted as hostile, hazardous, contaminated, and devoid of safe human interaction (Items 11, 14, and 15).
• The Future: Conceptualized as economically bleak, perpetually locked down, or culminating in death (Items 9 and 10).

Learned Helplessness and Behavioral Activation Theories

Martin Seligman’s theory of learned helplessness (Abramson, Seligman, & Teasdale, 1978) highlights that organisms exposed to uncontrollable aversive stimuli eventually cease adaptive behavior, succumbing to passivity and depressive dysphoria. Public health lockdowns, stay-at-home mandates, and travel bans removed personal agency over environmental reinforcement. When viewed through the lens of behavioral activation theory (Martell, Addis, & Jacobson, 2001), the abrupt termination of reinforcing social interactions, vocational routines, sports, and congregational gatherings eliminated positive response-contingent reinforcement, inevitably precipitating clinical anhedonia, fatigue, and vegetative withdrawal (Items 2, 4, 13, and 16).

Validity

Psychometric validation of the COVID-19DS was executed systematically using modern structural and criterion validation protocols (Dadfar et al., 2023), confirming robust psychometric integrity across diverse psychometric dimensions.

Construct and Criterion-Related Validity

Criterion and construct validity were substantiated by correlating the COVID-19DS against established health markers, particularly the Perceived Health-Related Components Scale. The theoretical postulate that severe pandemic-related depression undermines self-appraised vitality and overall health status was strongly confirmed:

• Total Score Correlation: The overall COVID-19DS score exhibited a statistically significant, moderate-to-strong negative correlation with perceived health components ($r = -.414$, $p < .001$). Individuals manifesting elevated pandemic depressive pathology appraised their physical, social, and functional well-being as severely compromised.
• Factor 1 Subscale Association: The Affective, Cognitive, and Somatic/Vegetative factor demonstrated a robust inverse correlation with perceived health ($r = -.376$, $p < .001$), reflecting how somatic lethargy, guilt, and cognitive indecisiveness correlate with reduced perceived somatic functioning.
• Factor 2 Subscale Association: The COVID-19 Depression factor similarly correlated inversely with perceived health ($r = -.369$, $p < .001$), highlighting that contagion fear, media exhaustion, and physical isolation exert tangible impacts on subjective vitality.

Known-Groups Validity

Consistent with international epidemiological findings during public health crises, known-groups validity was established through gender-based differential analyses. Female participants demonstrated significantly elevated COVID-19DS scores compared to male counterparts ($p < .01$). Concurrently, female participants reported significantly diminished perceived health scores ($p < .01$), reflecting established biological and socio-environmental vulnerabilities to stress-induced mood dysregulation documented across disaster and trauma literature.

Reliability

The scale demonstrates excellent empirical reliability, meeting all psychometric standards required for both research instrumentation and individual clinical screening applications:

• Internal Consistency: Evaluation of the complete 16-item scale yielded an overall Cronbach’s alpha ($lpha$) of .92, indicating exceptional internal consistency without evidence of item redundancy. Corrected item-total correlations across all 16 items exceeded psychometric retention thresholds ($r > .40$), confirming that each question assesses variance congruent with the overarching depressive distress construct.
• Subscale Consistency: Both derived subscales demonstrated robust internal consistency, with Factor 1 exhibiting reliability coefficients in the .87–.90 range and Factor 2 demonstrating coefficients between .82 and .86 across demographic cohorts.
• Measurement Precision: The high composite reliability minimizes the standard error of measurement (SEM), providing practitioners with high diagnostic precision when screening students and community members for critical pandemic affective decompensation.

Factor Analysis

The latent structural validity of the COVID-19DS was systematically established using both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) within a validation cohort of university students (Dadfar, Lester, & Turan, 2023).

Exploratory Factor Analysis (EFA)

Prior to extraction, sampling adequacy and data factorability were confirmed via the Kaiser-Meyer-Olkin (KMO) measure and Bartlett’s Test of Sphericity, both achieving statistical significance. Principal axis factoring with oblique rotation yielded a clean, distinct two-factor solution based on eigenvalues exceeding unity (> 1.0) and scree plot inspection. Cumulatively, these two salient latent dimensions accounted for 57.22% of the total explained variance:

• Factor 1: Affective, Cognitive, and Somatic/Vegetative: Clustered items capturing traditional depressive symptomatology, including persistent depressed mood, loss of pleasure, somatic fatigue, energy depletion, guilt, feelings of worthlessness, decision paralysis, thoughts of death, and emptiness.
• Factor 2: COVID-19 Depression: Grouped items addressing contextual, reactive pandemic phenomena, including contagion-related appetite changes, grief over infected peers, media-induced distress, quarantine melancholy, isolation sadness, and the sorrow associated with religious/ceremonial cancellations.

Confirmatory Factor Analysis (CFA)

To cross-validate the exploratory structure, a CFA utilizing the Maximum Likelihood (ML) estimation method was performed on the two-factor model. Goodness-of-fit indices demonstrated an outstanding fit to empirical data, meeting or exceeding modern psychometric benchmark standards (Hu & Bentler, 1999):

• Chi-Square ($\chi^2$): 244.146
• Normed Chi-Square ($\chi^2/df$ or CMIN/DF): 2.181 (well below the conservative threshold of 3.0, indicating strong structural fit)
• Goodness of Fit Index (GFI): .916
• Normed Fit Index (NFI): .908
• Relative Fit Index (RFI): .889
• Incremental Fit Index (IFI): .943
• Tucker-Lewis Index (TLI): .932
• Comparative Fit Index (CFI): .943 (exceeding the standard .90 criterion)
• Standardized Root Mean Square Residual (SRMR): .040 (well below the .08 cut-off, confirming minimal residual discrepancy)
• Root Mean Square Error of Approximation (RMSEA): .068 (with 90% confidence intervals within acceptable ranges, below the .08 ceiling)

These robust goodness-of-fit indices confirm that the two-factor multidimensional model represents the underlying latent organization of pandemic-related depressive symptomatology accurately.

Instrument / Measurement Tool

• Test Type: Original self-report screening instrument and psychometric questionnaire.
• Administration Format: Paper-and-pencil or digital/computer-assisted self-administered survey.
• Target Population: Adults and university student populations (adaptable for adolescent and geriatric demographic research).
• Completion Time: Approximately 3 to 5 minutes.
• Item Count: 16 items structured under a unified contextual prompt.
• Response Scale: 5-point Likert rating scale capturing symptom frequency over the preceding two weeks:
  • 0 = Not at all
  • 1 = Several days
  • 2 = More than half the days
  • 3 = Most days
  • 4 = Nearly every day over the last 2 weeks
• Scoring System and Interpretation:
  • Total Score Range: 0 to 64. Obtained by calculating the unweighted linear sum of all 16 items.
  • Subscale Scores: Subscale indices are derived by summing designated items:
    • Factor 1 (Affective, Cognitive, and Somatic/Vegetative): Sum of items reflecting classic depressive phenotypes (Items 1, 2, 4, 5, 8, 9, 10, etc.).
    • Factor 2 (COVID-19 Depression): Sum of items capturing situationally reactive stressors (Items 3, 6, 7, 11, 12, 13, 14, 15, 16).
  • Clinical Interpretation: Higher total scores denote elevated levels of COVID-19-induced depressive severity. Individuals falling into top-quartile distributions (extremely high scores) require immediate clinical triage, qualitative diagnostic interviews, and targeted psycho-educational or psychotherapeutic support.

Permissions & Fee and Test Year

• Year of Development: 2023.
• Copyright & Licensing: The scale was developed by Dr. Mahboubeh Dadfar, Dr. David Lester, and Dr. Yahya Turan and published in Taylor & Francis’s peer-reviewed journal Mental Health, Religion & Culture.
• Permissions: The COVID-19DS is a non-commercial academic measurement instrument. It is made available without licensing fees for academic, clinical non-profit, and scientific research endeavors. Researchers intending to reproduce, validate, or translate the tool into other languages should obtain standard formal permissions through the publisher (Taylor & Francis) or by contacting corresponding author Dr. Mahboubeh Dadfar ([email protected]).

References

• Abramson, L. Y., Seligman, M. E., & Teasdale, J. D. (1978). Learned helplessness in humans: Critique and reformulation. Journal of Abnormal Psychology, 87(1), 49–74. https://doi.org/10.1037/0021-843X.87.1.49
• Beck, A. T. (1979). Cognitive therapy of depression. Guilford Press.
• Dadfar, M., Lester, D., & Turan, Y. (2023). The development and validation of the COVID-19 Depression Scale (COVID-19DS): Association with the Perceived Health-Related Components Scale. Mental Health, Religion & Culture, 26(6), 550–567. https://doi.org/10.1080/13674676.2021.1978958
• Hu, L. T., & Bentler, P. M. (1999). Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Structural Equation Modeling: A Multidisciplinary Journal, 6(1), 1–55. https://doi.org/10.1080/10705519909540118
• Martell, C. R., Addis, M. E., & Jacobson, N. S. (2001). Depression in context: Strategies for guided action. W. W. Norton & Co.
• Monroe, S. M., & Simons, A. D. (1991). Diathesis-stress theories in the context of life-stress research: Implications for the depressive disorders. Psychological Bulletin, 110(3), 406–425. https://doi.org/10.1037/0033-2909.110.3.406

13. Items of the Scale (Questionnaire)